JP2012528813A5 - - Google Patents

Download PDF

Info

Publication number
JP2012528813A5
JP2012528813A5 JP2012513512A JP2012513512A JP2012528813A5 JP 2012528813 A5 JP2012528813 A5 JP 2012528813A5 JP 2012513512 A JP2012513512 A JP 2012513512A JP 2012513512 A JP2012513512 A JP 2012513512A JP 2012528813 A5 JP2012528813 A5 JP 2012528813A5
Authority
JP
Japan
Prior art keywords
composition according
formula
group
alkyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012513512A
Other languages
English (en)
Japanese (ja)
Other versions
JP5837481B2 (ja
JP2012528813A (ja
Filing date
Publication date
Priority claimed from GB0909643A external-priority patent/GB0909643D0/en
Application filed filed Critical
Publication of JP2012528813A publication Critical patent/JP2012528813A/ja
Publication of JP2012528813A5 publication Critical patent/JP2012528813A5/ja
Application granted granted Critical
Publication of JP5837481B2 publication Critical patent/JP5837481B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012513512A 2009-06-04 2010-06-04 糸球体腎炎治療 Expired - Fee Related JP5837481B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0909643A GB0909643D0 (en) 2009-06-04 2009-06-04 Glomerulonephritis treatment
GB0909643.9 2009-06-04
PCT/EP2010/003384 WO2010139482A1 (en) 2009-06-04 2010-06-04 Glomerulonephritis treatment

Publications (3)

Publication Number Publication Date
JP2012528813A JP2012528813A (ja) 2012-11-15
JP2012528813A5 true JP2012528813A5 (https=) 2014-05-08
JP5837481B2 JP5837481B2 (ja) 2015-12-24

Family

ID=40936918

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012513512A Expired - Fee Related JP5837481B2 (ja) 2009-06-04 2010-06-04 糸球体腎炎治療

Country Status (14)

Country Link
US (3) US20120136066A1 (https=)
EP (2) EP2745837B1 (https=)
JP (1) JP5837481B2 (https=)
AU (1) AU2010256013B2 (https=)
CA (1) CA2764465C (https=)
CY (1) CY1118269T1 (https=)
DK (2) DK2437739T3 (https=)
ES (2) ES2587719T3 (https=)
GB (1) GB0909643D0 (https=)
HU (2) HUE030085T2 (https=)
LT (1) LT2745837T (https=)
PL (2) PL2437739T3 (https=)
PT (2) PT2745837T (https=)
WO (1) WO2010139482A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201014633D0 (en) * 2010-09-02 2010-10-13 Avexxin As Rheumatoid arthritis treatment
GB201205394D0 (en) 2012-03-27 2012-05-09 Adlens Ltd Improvements in or relating to deformable non-round membrane assemblies
GB201221329D0 (en) * 2012-11-27 2013-01-09 Avexxin As Dermatitis treatment
GB201313238D0 (en) 2013-07-24 2013-09-04 Avexxin As Process for the preparation of a polyunsaturated ketone compound
GB201409363D0 (en) 2014-05-27 2014-07-09 Avexxin As Skin cancer treatment
GB201501144D0 (en) 2015-01-23 2015-03-11 Avexxin As Process for the preparation of a polyunsaturated ketone compound
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
EP3515422A1 (en) * 2016-09-21 2019-07-31 Avexxin AS Pharmaceutical composition
EP3638221B1 (en) * 2017-06-16 2021-09-29 Avexxin AS Compositions and methods for treatment of a fibrotic disease
GB201910644D0 (en) 2019-07-25 2019-09-11 Coegin Pharma As Cancer Treatment

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670465A (en) * 1986-05-21 1987-06-02 Syntex (U.S.A.) Inc. Arachidonic acid analogs
JPH0987176A (ja) * 1995-09-26 1997-03-31 Shiseido Co Ltd 糸球体腎炎抑制剤
JPH09268153A (ja) 1996-04-02 1997-10-14 Sagami Chem Res Center トリフルオロメチルケトン誘導体及びホスホリパーゼa2阻害剤
JP2000508645A (ja) * 1996-04-12 2000-07-11 ペプテック リミテッド ポリ不飽和脂肪酸を使用する免疫病の治療方法
US6107334A (en) 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US7605149B1 (en) 1998-07-13 2009-10-20 University Of South Florida Modulation of the phospholipase A2 pathway as a therapeutic
US6031014A (en) 1998-12-08 2000-02-29 Crivello; James V. Initiator compositions and methods for their synthesis and use
WO2002060535A1 (en) * 2001-01-31 2002-08-08 Leff Alan R Method of treating inflammatory conditions by inhibiting cytosolic phospholipase a¿2?
GB0202002D0 (en) * 2002-01-29 2002-03-13 Leiv Eiriksson Nyotek A S Use
MY131170A (en) * 2002-03-28 2007-07-31 Nissan Chemical Ind Ltd Therapeutic agent for glomerular disease
JP2006520335A (ja) * 2003-03-18 2006-09-07 ノバルティス アクチエンゲゼルシャフト 脂肪酸とアミノ酸を含有する組成物
NZ552238A (en) 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
US20100144827A1 (en) * 2006-12-20 2010-06-10 Medwell Laboratories Ltd. C/O Ngt Technological Incubator Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof
JP5620272B2 (ja) * 2007-11-09 2014-11-05 プロノヴァ・バイオファーマ・ノルゲ・アーエスPronova BioPharma NorgeAS 化粧品において,食品サプリメントとして,または医薬品として用いるための脂質化合物

Similar Documents

Publication Publication Date Title
JP2012528813A5 (https=)
JP2011518833A5 (https=)
JP2012092103A5 (https=)
JP2011088902A5 (https=)
JP2015537020A5 (https=)
JP2011518218A5 (https=)
JP2014029971A5 (ja) 有機化合物
JP2012144574A5 (https=)
JP2010500293A5 (https=)
JP2016503797A5 (https=)
JP2009538336A5 (https=)
JP2009539914A5 (https=)
JP2011523952A5 (https=)
JP2012054542A5 (ja) トリアゾール誘導体および複素環化合物
JP2013526497A5 (https=)
JP2010510232A5 (https=)
JP2010508310A5 (https=)
JP2012513982A5 (https=)
RU2011108663A (ru) Способы получения метилового эфира 4-оксооктагидроиндол-1-карбоновой кислоты и ее производные
JP2011190277A5 (https=)
JP2010507590A5 (https=)
JP2015509966A5 (https=)
JP2010505869A5 (https=)
JP2012006843A5 (https=)
JP2009522364A5 (https=)